Pharma Aids Limited (DSE:PHARMAID)
Bangladesh · Delayed Price · Currency is BDT 569.50
-7.20 (-1.25%)
At close: Jun 15, 2026
Pharma Aids Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 12, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 1,783 | 1,671 | 2,086 | 2,467 | 2,543 | 1,241 | |
Market Cap Growth | 11.30% | -19.89% | -15.46% | -2.98% | 104.82% | -2.50% |
Enterprise Value | 1,761 | 1,651 | 2,039 | 2,459 | 2,502 | 1,228 |
Last Close Price | 571.40 | 532.40 | 661.81 | 781.79 | 800.73 | 387.17 |
PE Ratio | 22.96 | 26.18 | 34.09 | - | 73.14 | 24.70 |
PS Ratio | 3.60 | 3.81 | 4.95 | 8.00 | 7.87 | 4.43 |
PB Ratio | 3.67 | 3.86 | 6.08 | 8.66 | 8.25 | 4.27 |
P/TBV Ratio | 3.67 | 3.86 | 6.08 | 8.66 | 8.25 | 4.27 |
P/FCF Ratio | 264.63 | - | 92.27 | 487.65 | 87.25 | 58.77 |
P/OCF Ratio | 28.34 | 42.02 | 91.53 | 339.47 | 75.13 | 39.53 |
EV/Sales Ratio | 3.55 | 3.77 | 4.84 | 7.97 | 7.74 | 4.38 |
EV/EBITDA Ratio | 15.50 | 18.36 | 22.34 | 134.45 | 40.46 | 16.47 |
EV/EBIT Ratio | 16.92 | 19.79 | 24.18 | 230.56 | 46.32 | 18.52 |
EV/FCF Ratio | 261.38 | - | 90.23 | 485.99 | 85.84 | 58.15 |
Debt / Equity Ratio | 0.04 | 0.06 | 0.05 | 0.04 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.15 | 0.30 | 0.20 | 0.63 | 0.02 | 0.00 |
Debt / FCF Ratio | 2.56 | - | 0.80 | 2.27 | 0.03 | 0.01 |
Net Debt / Equity Ratio | -0.04 | 0.04 | -0.04 | -0.01 | -0.08 | -0.07 |
Net Debt / EBITDA Ratio | -0.19 | 0.18 | -0.16 | -0.20 | -0.39 | -0.26 |
Net Debt / FCF Ratio | -3.25 | -0.93 | -0.64 | -0.72 | -0.82 | -0.93 |
Asset Turnover | 0.81 | 0.83 | 0.98 | 0.81 | 0.89 | 0.85 |
Inventory Turnover | 4.72 | 4.88 | 4.92 | 4.27 | 4.26 | 5.48 |
Quick Ratio | 1.48 | 1.33 | 1.36 | 1.77 | 2.50 | 3.47 |
Current Ratio | 3.20 | 3.33 | 3.06 | 3.26 | 4.32 | 5.17 |
Return on Equity (ROE) | 17.19% | 16.46% | 19.50% | -2.15% | 11.60% | 18.32% |
Return on Assets (ROA) | 10.57% | 9.83% | 12.24% | 1.75% | 9.35% | 12.60% |
Return on Invested Capital (ROIC) | 17.52% | 16.65% | 20.03% | -2.34% | 12.62% | 19.62% |
Return on Capital Employed (ROCE) | 21.30% | 19.20% | 24.60% | 3.70% | 17.50% | 22.80% |
Earnings Yield | 4.36% | 3.82% | 2.93% | -0.26% | 1.37% | 4.05% |
FCF Yield | 0.38% | -1.04% | 1.08% | 0.21% | 1.15% | 1.70% |
Dividend Yield | 0.53% | 0.56% | 0.38% | 0.13% | 0.62% | 1.29% |
Payout Ratio | 12.49% | 12.01% | 7.90% | - | 72.69% | 29.94% |
Total Shareholder Return | 0.52% | 0.56% | 0.38% | 0.13% | 0.62% | 1.29% |